MCK McKesson Corporation
USHealthcareAs of 2026-07-10 16:00
Why MCK matters now
McKesson Corporation (MCK) is a US stock in Healthcare. The latest InvestLog snapshot shows $805.96 with +1.66% on the session and $94.36B in market capitalization; recent performance reads 1-month -1.48% and YTD -8.49%.
The latest financial table shown here is Q4 2026, with revenue of $96.30B, net income of $1.68B, and EPS of $13.71. Investors can compare that operating picture with valuation signals such as P/E 24.78 and FCF yield 6.8%.
The latest indexable market news headline is "Brokers Suggest Investing in McKesson (MCK): Read This Before Placing a Bet" from Zacks Investment Research.
Additional event context on this page matters because analyst consensus is Buy with a median target of $970.00; recent insider activity includes TYLER BRIAN S. filing S-Sale; recent congressional disclosure data includes Lizzie Fletcher Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
24.78
PEG
0.46
P/B
-42.20
P/S
0.22
EV/EBITDA
13.19
DCF Value
$1,295.76
FCF Yield
6.8%
Div Yield
0.4%
Margins & Returns
Gross Margin
3.6%
Operating Margin
1.6%
Net Margin
1.2%
ROE
-265.4%
ROA
5.8%
ROIC
31.1%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2026 | $96.30B | $1.68B | $13.71 |
| FY 2026 | $403.43B | $4.76B | $38.38 |
| Q3 2026 | $106.16B | $1.19B | $9.59 |
| Q2 2026 | $103.15B | $1.11B | $8.92 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$994.86
Target (Median)
$970.00
Target Range
$875.00 - $1,085.00
Trading Activity
Insider Trades
Congress Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Distribution
Country
US
Exchange
—
Beta
0.32
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.